Company Filing History:
Years Active: 2019-2023
Title: Annick Desjardins: Pioneering Innovations in Oncolytic Virus Therapy
Introduction
Annick Desjardins is a prominent inventor based in Durham, NC (US), known for her groundbreaking work in the field of oncolytic virus therapy. With a total of 5 patents to her name, she has made significant contributions to cancer treatment through innovative approaches.
Latest Patents
One of her latest patents involves the use of an oncolytic poliovirus for human tumors. This human clinical application of a chimeric poliovirus construct has demonstrated excellent anti-tumor effects. The mechanism of action is believed to involve both viral oncolysis and immune recruitment, leading to necrosis in the tumor area. Remarkably, no adverse effects have been observed in the patients treated with this innovative therapy.
Career Highlights
Annick Desjardins is affiliated with Duke University, where she continues to advance her research in oncolytic virus therapy. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.
Collaborations
She has collaborated with notable colleagues, including Matthias Gromeier and John Howard Sampson, who share her commitment to advancing cancer research.
Conclusion
Annick Desjardins stands out as a leading inventor in the field of oncolytic virus therapy, with her innovative patents paving the way for new cancer treatments. Her contributions are vital to the ongoing fight against cancer, and her work continues to inspire future research in this area.